![Vincent Rajkumar: Updated Active Drugs in myeloma with mechanism of action](https://oncodaily.com/pub/uploads/2024/03/MYis_acO_400x400-e1719315141907.png)
Vincent Rajkumar: Updated Active Drugs in myeloma with mechanism of action
Vincent Rajkumar shared a post on X:
“Updated Active Drugs in myeloma with mechanism of action in one slide.
FDA Approved drugs: Black font
Investigational: Blue font.”
Source: Vincent Rajkumar/X
Vincent Rajkumar is a Professor of Medicine at the Mayo Clinic in Rochester, Minnesota, and Chair for the Mayo Clinic Myeloma, Amyloidosis, and Dysproteinemia Group. He also chairs the Board of directors of The International Myeloma Foundation and the Eastern Cooperative Oncology Group (ECOG) Myeloma Committee.
His extensive contributions include over 230 peer-reviewed publications, predominantly focusing on multiple myeloma and related plasma cell disorders. Furthermore, Dr. Rajkumar is a Section Editor for multiple myeloma and related disorders for Leukemia and an Associate Editor for the Mayo Clinic Proceedings.